Nationwide launch in Japan
STOCKHOLM, March 30th 2017, Moberg Pharma AB (OMX: MOB). Following a successful test launch in Japan, Moberg Pharma’s local partner CMIC Group initiates a national roll-out of Zanmira® Nail (Kerasal Nail®) in several major cities during the second quarter.The Asian-Pacific roll-out of Kerasal Nail® continues. The initial consumer response to the Japanese test launch of Zanmira® Nail (local brand) conducted by Menarini through local partner CMIC Group in 2016 was strong. Following this, CMIC Group now initiates a national roll-out targeting multiple major cities and more than 8 000 stores